Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

@article{Lip2010RefiningCR,
  title={Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.},
  author={Gregory Y H Lip and Robby Nieuwlaat and Ron Pisters and Deirdre A. Lane and Harry J.G.M. Crijns},
  journal={Chest},
  year={2010},
  volume={137 2},
  pages={
          263-72
        }
}
  • Gregory Y H Lip, Robby Nieuwlaat, +2 authors Harry J.G.M. Crijns
  • Published 2010
  • Medicine
  • Chest
  • BACKGROUND Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. [...] Key MethodRESULTS Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75…Expand Abstract

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    This is a single center (remote), prospective, unblinded, randomized interventional study (3 studies in one) to determine the rate of physician-diagnosed atrial fibrillation (AF) in a… Expand
    ConditionsAtrial Fibrillation
    InterventionDevice
    OBSERVATIONAL PATIENT REGISTRY CLINICAL TRIAL
    The aim of IRIS study is to observe the safety and efficacy of Rivaroxaban in subjects undergoing catheter ablation for atrial fibrillation (AF) in real-world clinical practice… Expand
    ConditionsAtrial Fibrillation
    InterventionDrug, Procedure
    INTERVENTIONAL CLINICAL TRIAL
    Background: Oral anticoagulant drugs represent an essential tool in thrombo-embolic events prevention. Most used are vitamin K antagonists (VKA), which plasma level is monitored… Expand
    ConditionsBlood Coagulation Tests, Health Education, Patient Education as Topic
    InterventionBehavioral
    OBSERVATIONAL PATIENT REGISTRY CLINICAL TRIAL
    The primary aim of the present study is to screen high-risk type 2 diabetes patients and heart failure patients without any history of atrial fibrillation (AF), ongoing oral… Expand
    ConditionsAtrial Fibrillation
    InterventionOther

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 3,044 CITATIONS, ESTIMATED 41% COVERAGE

    Putting risk prediction in atrial fibrillation into perspective.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    The improved but unfinished business of stroke risk stratification in atrial fibrillation.

    VIEW 2 EXCERPTS
    CITES BACKGROUND & METHODS

    Stroke risk stratification in atrial fibrillation: a review of common risk factors

    VIEW 2 EXCERPTS
    CITES METHODS & BACKGROUND

    FILTER CITATIONS BY YEAR

    2008
    2020

    CITATION STATISTICS

    • 154 Highly Influenced Citations

    • Averaged 377 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 35 REFERENCES